GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Autek China 300595.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

10.48

-1.78%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥1.85bn

FY2016FY2025

Net income

CN¥479.5m

FY2016FY2025

Free cash flow

CN¥706.7m

FY2016FY2025

Shareholders' equity

CN¥4.91bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥1.85bnCN¥1.81bnCN¥1.74bnCN¥1.53bnCN¥1.30bnCN¥870.7mCN¥646.9mCN¥458.4mCN¥311.6mCN¥235.0m
Gross profitCN¥1.21bnCN¥1.33bnCN¥1.30bnCN¥1.17bnCN¥993.1mCN¥683.8mCN¥507.2mCN¥357.5mCN¥237.5mCN¥174.1m
Research and developmentCN¥43.9mCN¥42.3mCN¥40.3mCN¥33.6mCN¥27.3mCN¥19.0mCN¥16.1mCN¥12.8mCN¥10.4mCN¥7.8m
Operating incomeCN¥635.0mCN¥739.3mCN¥855.7mCN¥798.5mCN¥684.6mCN¥474.0mCN¥333.7mCN¥245.3mCN¥179.0mCN¥124.1m
Net incomeCN¥479.5mCN¥572.2mCN¥666.6mCN¥623.8mCN¥554.7mCN¥433.3mCN¥306.9mCN¥216.2mCN¥150.9mCN¥114.0m
Diluted earnings per share0.540.650.740.690.650.510.360.260.180.15

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥6.30bnCN¥6.03bnCN¥5.52bnCN¥5.12bnCN¥2.97bnCN¥2.21bnCN¥1.61bnCN¥1.23bnCN¥922.6mCN¥357.5m
Cash and short-term investmentsCN¥3.20bnCN¥2.01bnCN¥3.17bnCN¥2.29bnCN¥1.35bnCN¥1.31bnCN¥461.5mCN¥178.3mCN¥165.6mCN¥229.6m
Total liabilitiesCN¥849.5mCN¥887.2mCN¥807.9mCN¥523.0mCN¥436.4mCN¥221.7mCN¥168.2mCN¥145.3mCN¥110.2mCN¥41.6m
DebtCN¥307.6mCN¥202.4mCN¥182.9mCN¥225.3mCN¥163.6mCN¥1.0mCN¥200,000CN¥48.7mCN¥42.6m—
Shareholders' equityCN¥4.91bnCN¥4.70bnCN¥4.35bnCN¥4.23bnCN¥2.22bnCN¥1.75bnCN¥1.33bnCN¥1.02bnCN¥805.0mCN¥311.5m
Shares outstanding895m886m897m904m850m851m851m839m851m778m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥827.4mCN¥684.9mCN¥723.4mCN¥651.7mCN¥630.1mCN¥380.9mCN¥275.4mCN¥148.5mCN¥144.7mCN¥108.8m
Capital spending−CN¥120.7m−CN¥206.6m−CN¥197.9m−CN¥129.4m−CN¥137.8m−CN¥94.4m−CN¥57.1m−CN¥35.3m−CN¥62.8m−CN¥28.6m
Free cash flowCN¥706.7mCN¥478.3mCN¥525.5mCN¥522.3mCN¥492.3mCN¥286.5mCN¥218.3mCN¥113.3mCN¥81.9mCN¥80.2m
Dividends paid−CN¥250.9m−CN¥203.3m−CN¥125.2m−CN¥124.4m−CN¥124.5m−CN¥40.5m−CN¥31.4m−CN¥25.1m−CN¥23.8m−CN¥73.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥405.8mCN¥459.4mCN¥428.4mCN¥562.1mCN¥392.5mCN¥478.2mCN¥382.6mCN¥547.7m
Gross profitCN¥272.7mCN¥329.0mCN¥269.1mCN¥411.4mCN¥274.2mCN¥362.8mCN¥257.8mCN¥418.9m
Operating incomeCN¥111.5mCN¥163.2mCN¥41.9mCN¥232.2mCN¥124.3mCN¥203.4mCN¥64.1mCN¥261.2m
Net incomeCN¥85.7mCN¥146.2mCN¥37.5mCN¥192.1mCN¥89.7mCN¥160.3mCN¥49.7mCN¥198.2m
Diluted earnings per share0.100.160.040.210.100.180.060.22
Cash from operations——CN¥170.0mCN¥291.0mCN¥117.0mCN¥198.0m—CN¥285.0m
Capital spending−CN¥17.0m−CN¥19.0m−CN¥35.0m−CN¥26.0m−CN¥20.0m−CN¥38.0m−CN¥48.0m−CN¥49.0m
Free cash flow——CN¥135.0mCN¥265.0mCN¥97.0mCN¥160.0m—CN¥236.0m
Total assetsCN¥6.12bnCN¥6.40bnCN¥6.30bnCN¥6.42bnCN¥6.01bnCN¥6.28bnCN¥6.03bnCN¥6.02bn
Cash and short-term investments——CN¥3.20bnCN¥2.07bnCN¥2.10bnCN¥2.11bnCN¥2.01bnCN¥2.18bn
DebtCN¥10.0m—CN¥160.4mCN¥118.4mCN¥16.0mCN¥18.0mCN¥17.1mCN¥14.0m
Shareholders' equityCN¥5.03bnCN¥5.06bnCN¥4.91bnCN¥4.94bnCN¥4.74bnCN¥4.85bnCN¥4.70bnCN¥4.66bn

Financial ratios

Data as of 1 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin65.4%73.2%74.7%76.9%76.7%78.5%—
Operating margin35.5%40.8%49.3%52.4%52.9%54.4%—
Net margin25.9%31.6%38.4%40.9%42.8%49.8%—
Return on equity9.8%12.2%15.3%14.7%25.0%24.7%—
Return on assets7.6%9.5%12.1%12.2%18.7%19.6%—
Free cash flow yield10.4%9.9%10.1%8.5%8.9%5.5%—
Revenue growth2.0%4.4%13.9%17.8%48.7%34.6%—
Earnings growth-16.2%-14.2%6.9%12.5%28.0%41.2%—
Current ratio5.77x5.87x6.32x10.89x6.28x7.87x—
Debt to equity0.03x0.00x0.00x0.00x—0.00x0.00x
Equity ratio78.0%77.9%78.8%82.6%74.5%79.2%—
Interest coverage39.33x47.53x70.48x76.54x79.22x345.57x—
R&D as a share of sales2.4%2.3%2.3%2.2%2.1%2.2%—
Buybacks as a share of market value-1.0%1.2%0.7%-6.4%0.2%-0.1%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue6.6%16.3%26.5%
Operating income-7.4%6.0%20.1%
Net income-8.4%2.0%18.4%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin69.3%72.3%73.5%74.2%
Operating margin37.5%43.7%46.1%47.3%
Net margin28.7%33.8%36.6%38.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings27.429.430.451.787.9114.962.539.842.0
Price to sales7.19.311.721.137.657.229.618.820.3

Dividends and splits

Per share, in the currency the company pays

Paid for 9 years. Last went ex-dividend on 5 Nov 2025.

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Paid in the year0.280.2230.140.1460.1450.0470.0370.03
  • 1.037-for-1 split · 21 May 2021
  • 3-for-2 split · 20 May 2020
  • 9-for-5 split · 17 May 2019
  • 9-for-5 split · 25 May 2018
  • 9-for-5 split · 23 May 2017

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.